GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra ® (ofatumumab), a CD20-directed ... News-Medical.Net, 32 minutes ago
US FDA approves ofatumumab - Express Pharma, 2 days ago
FDA Grants Full Approval to Ofatumumab (Arzerra) for CLL - General Medicine eJournal, 3 days ago
The US Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation for Boehringer Ingelheim's volasertib for the treatment of patients with acute myeloid leukaemia (AML). AML is an aggressive cancer of the ...PharmaBiz, 3 hours ago Breathe Technologies gets US FDA 510(k) clearance to its NIOV System for use with compressed gas PharmaBiz, 2 days ago FDA Clears Breathe Tech's NIOV System For Respiratory Insufficiency Pharmaceutical Online, 3 days ago Boehringer Ingelheim´s Volasertib gets orphan drug designation in EU, US Bio Spectrum Asia, 3 days ago
4/20/14 - Dyax Receives FDA Approval to Expand Use of KALBITOR® ecallantide for the Treatment of Acute Attacks of Hereditary Angioedema to Patients 12 Years of...
Dyax Receives FDA Approval to Expand Use of KALBITOR ecallantide for the Treatment of Acute Attacks of Hereditary Angioedema to Patients 12 Years of Age and Older By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA Dyax Corp.Pharmacy Choice, 20 hours ago Merck receives FDA approval for ragweed pollen-induced allergic rhinitis drug Individual.com, 2 days ago Allergy Pills Newly Approved by FDA Could Provide Relief The Guardian Express, 2 days ago FDA OKs Ragwitek Hay Fever Tablet MedPage Today, 2 days ago
Bans imposed by FDA on Indian firms in world's largest drug market take a toll Sushmi Dey | New Delhi April 19, 2014 Last Updated at 21:28 IST India's drug export growth in 2013-14 may have dipped sharply from the projected 16-17 per cent to six-seven per ...Business Standard, 1 day ago US Food and Drug regulator to deploy more inspectors in India Economic Times, 2 months ago Indian Medicines Come Under Increased Scrutiny: U.S. FDA Silicon India, 2 months ago India questions FDA actions on drug firms Deccan Herald, 2 months ago
In a major crackdown against the illegal export of drugs to foreign countries, the Food and Drug Administration (FDA) has seized drugs worth Rs2.47 crore from 28 locations in three months. It has also registered FIRs against nine people, including ...DNA India, 1 day ago
Laparoscopic power morcellators should no longer be used for hysterectomy or myomectomy in most women with uterine fibroids because of the risk of spreading unsuspected cancerous tissue, the US Food and Drug Administration (FDA) announced today. ...Diabetes Care, 3 days ago FDA warns of cancer risk with fibroid procedure Denver Post, 3 days ago FDA Warns Against Hysterectomy Technique That May Spread Cancer Yahoo! News, 3 days ago FDA Warns Against Procedure for Uterine Fibroids Health Finder, 3 days ago
The U.S. Food and Drug Administration said Thursday that a procedure commonly used during hysterectomies and fibroid surgeries can spread undetected cancer. The procedure, called power morcellation, is used to grind up tissue so it can be removed ...USA Today, 3 days ago FDA warns common uterine fibroid surgery can spread undetected cancer CNBC, 3 days ago UPDATE 1-FDA warns common uterine fibroid surgery can spread undetected cancer Reuters, 3 days ago
More from: Reuters, Reuters UK...and 7 other sources
Syneron Medical Ltd., ( ELOS ) FDA Clearance of the UltraShape System Conference Call April 17, 2014 8:30 AM ET Operator Good day, ladies and gentlemen and welcome to the Syneron Medical Ltd., Conference Event. At this time, all participants ...Seeking Alpha, 3 days ago US FDA grants marketing approval to Syneron Medical's UltraShape System for fat cell destruction PharmaBiz, 4 days ago FDA clearance to market the UltraShape System Today's Medical Developments, 4 days ago Syneron to Host Conference Call and Webcast to Discuss UltraShape FDA Clearance TickerTech.com, 4 days ago
More from: Finwin, Med India...and 20 other sources
The US Food and Drug Administration (FDA) has approved Boston Scientific Corporation's latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the Dynagen Mini and Inogen ...PharmaBiz, 4 days ago Boston Scientific wins US FDA approval for new generation ICDs and CRT-Ds defibrillators and heart failure devices MENAFN, 4 days ago Boston Sci gains FDA approval for devices in X4, Mini line Medical Device Daily, 4 days ago BSX wins FDA approval on heart devices WBJournal.com, 4 days ago
Glenmark Generics Inc., USA a subsidiary of Glenmark Generics Limited has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for eszopiclone tablets. Glenmark will commence ...PharmaBiz, 4 days ago PTI - DRL-GLENMARK(BCM9) - Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod Namibia Press Agency, 4 days ago Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod Economic Times, 4 days ago Dr Reddy’s launches insomnia drug in US, Glenmark gets FDA nod Business Line, 4 days ago
on your WebpageAdd Widget >Get your members hooked!